Cyberonics Announces Update On Hagerty Lawsuit

                Cyberonics Announces Update On Hagerty Lawsuit

PR Newswire

HOUSTON, Feb. 4, 2013

HOUSTON, Feb. 4, 2013 /PRNewswire/ --Cyberonics, Inc. (NASDAQ:CYBX) today
announced that the lawsuit filed by former employee Andrew Hagerty in federal
district court in Massachusetts was voluntarily dismissed without prejudice by
Mr. Hagerty on February 1, 2013. The company has asserted that, under the
terms of his employment, Mr. Hagerty's claims are subject to binding
arbitration. Mr. Hagerty has the right to re-file the lawsuit or to pursue a
resolution through binding arbitration.

About Cyberonics, Inc. and the VNS Therapy^® System
Cyberonics, Inc. is a medical technology company with core expertise in
neuromodulation. The company developed and markets the VNS Therapy System,
which is FDA-approved for the treatment of refractory epilepsy and
treatment-resistant depression. The VNS Therapy System uses a surgically
implanted medical device that delivers pulsed electrical signals to the vagus
nerve. Cyberonics markets the VNS Therapy System in selected markets
worldwide.

Additional information on Cyberonics and the VNS Therapy System is available
at www.cyberonics.com.

Contact information

Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
ir@cyberonics.com



SOURCE Cyberonics, Inc.

Website: http://www.cyberonics.com